PortfoliosLab logoPortfoliosLab logo
CSTL vs. USAR
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

CSTL vs. USAR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Castle Biosciences, Inc. (CSTL) and USA Rare Earth, Inc (USAR). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

CSTL vs. USAR - Yearly Performance Comparison


2026 (YTD)202520242023
CSTL
Castle Biosciences, Inc.
-36.89%45.97%23.49%30.79%
USAR
USA Rare Earth, Inc
27.18%3.66%11.13%2.58%

Fundamentals

EPS

CSTL:

-$0.82

USAR:

-$4.57

PS Ratio

CSTL:

2.09

USAR:

3.14

Total Revenue (TTM)

CSTL:

$344.23M

USAR:

$314.13M

Gross Profit (TTM)

CSTL:

$204.51M

USAR:

$254.80M

EBITDA (TTM)

CSTL:

$8.22M

USAR:

-$50.51M

Returns By Period

In the year-to-date period, CSTL achieves a -36.89% return, which is significantly lower than USAR's 27.18% return.


CSTL

1D
4.25%
1M
-16.98%
YTD
-36.89%
6M
7.82%
1Y
22.63%
3Y*
2.62%
5Y*
-19.15%
10Y*

USAR

1D
6.36%
1M
-19.92%
YTD
27.18%
6M
-11.95%
1Y
154.80%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CSTL vs. USAR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CSTL
CSTL Risk / Return Rank: 5656
Overall Rank
CSTL Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
CSTL Sortino Ratio Rank: 5858
Sortino Ratio Rank
CSTL Omega Ratio Rank: 5555
Omega Ratio Rank
CSTL Calmar Ratio Rank: 5454
Calmar Ratio Rank
CSTL Martin Ratio Rank: 5555
Martin Ratio Rank

USAR
USAR Risk / Return Rank: 7979
Overall Rank
USAR Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
USAR Sortino Ratio Rank: 8585
Sortino Ratio Rank
USAR Omega Ratio Rank: 7777
Omega Ratio Rank
USAR Calmar Ratio Rank: 8080
Calmar Ratio Rank
USAR Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CSTL vs. USAR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Castle Biosciences, Inc. (CSTL) and USA Rare Earth, Inc (USAR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CSTLUSARDifference

Sharpe ratio

Return per unit of total volatility

0.38

1.13

-0.75

Sortino ratio

Return per unit of downside risk

1.09

2.35

-1.27

Omega ratio

Gain probability vs. loss probability

1.13

1.25

-0.12

Calmar ratio

Return relative to maximum drawdown

0.51

2.23

-1.72

Martin ratio

Return relative to average drawdown

1.30

3.82

-2.52

CSTL vs. USAR - Sharpe Ratio Comparison

The current CSTL Sharpe Ratio is 0.38, which is lower than the USAR Sharpe Ratio of 1.13. The chart below compares the historical Sharpe Ratios of CSTL and USAR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


CSTLUSARDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.38

1.13

-0.75

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.26

Sharpe Ratio (All Time)

Calculated using the full available price history

0.03

0.16

-0.13

Correlation

The correlation between CSTL and USAR is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

CSTL vs. USAR - Dividend Comparison

Neither CSTL nor USAR has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CSTL vs. USAR - Drawdown Comparison

The maximum CSTL drawdown since its inception was -88.02%, which is greater than USAR's maximum drawdown of -69.23%. Use the drawdown chart below to compare losses from any high point for CSTL and USAR.


Loading graphics...

Drawdown Indicators


CSTLUSARDifference

Max Drawdown

Largest peak-to-trough decline

-88.02%

-69.23%

-18.79%

Max Drawdown (1Y)

Largest decline over 1 year

-45.33%

-69.23%

+23.90%

Max Drawdown (5Y)

Largest decline over 5 years

-84.97%

Current Drawdown

Current decline from peak

-74.78%

-60.87%

-13.91%

Average Drawdown

Average peak-to-trough decline

-54.08%

-17.18%

-36.90%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.78%

40.38%

-22.60%

Volatility

CSTL vs. USAR - Volatility Comparison

The current volatility for Castle Biosciences, Inc. (CSTL) is 9.82%, while USA Rare Earth, Inc (USAR) has a volatility of 25.45%. This indicates that CSTL experiences smaller price fluctuations and is considered to be less risky than USAR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


CSTLUSARDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.82%

25.45%

-15.63%

Volatility (6M)

Calculated over the trailing 6-month period

36.73%

88.99%

-52.26%

Volatility (1Y)

Calculated over the trailing 1-year period

59.76%

137.64%

-77.88%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

73.92%

104.05%

-30.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

74.42%

104.05%

-29.63%

Financials

CSTL vs. USAR - Financials Comparison

This section allows you to compare key financial metrics between Castle Biosciences, Inc. and USA Rare Earth, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M350.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
87.01M
1.64M
(CSTL) Total Revenue
(USAR) Total Revenue
Values in USD except per share items